Status:
ACTIVE_NOT_RECRUITING
Interdisciplinary Program to Improve Lifestyle in Chronic Pathology: Alt Pirineu Aran in Fit (APA-FIT)
Lead Sponsor:
University of Barcelona
Collaborating Sponsors:
CatSalut Catalonia, Spain
Conditions:
Non-communicable Diseases (NCD)
Cardiovascular Risk
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Interdisciplinary Program to Improve the Lifestyle of Individuals with Chronic Conditions in the Alt Pirineu and Aran Region Sedentary behavior and lack of regular physical activity have been widely ...
Detailed Description
Project Justification: Lifestyle, Physical Activity and Public Health A sedentary lifestyle and lack of regular physical activity have been widely recognised as major global public health concerns. T...
Eligibility Criteria
Inclusion
- Aged 18 years or older, diagnosed with one or more chronic conditions
- Classified as having moderate or high cardiovascular risk for physical activity Moderate Risk: Men ≥ 45 and women ≥ 55 years. Two or more cardiovascular (CV) risk factors High Risk: One or more signs or symptoms of cardiovascular, respiratory, or metabolic disease.Diagnosed cardiovascular or metabolic disease
- Referred by a primary care physician or community nurse who deems a lifestyle change necessary to improve health and quality of life
- Ownership of a smartphone with internet access, camera capability, and sufficient internal storage to install and run the APA-FIT app Participants meeting these criteria will be invited to enroll in the study and randomized to either the intervention or control arm for the Phase II evaluation. Continuous monitoring and follow-up will occur throughout the nine-month program and at 3- and 6-month post-intervention checkpoints.
Exclusion
- \[Not provided; assume standard medical or logistical exclusions will apply.\]
- Exclusion Criteria Phase II
- Severe visual or hearing impairments that would preclude participation in the intervention
- Significant cognitive disorders
- Dependence in activities of daily living
- Failure to adhere to the therapeutic commitment and/or provide informed consent
- Any medical condition that contraindicates physical activity or otherwise prevents completion of the program
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT07172490
Start Date
September 1 2024
End Date
December 30 2025
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Agrupació Europea de Cooperació Territorial
Puigcerdà, Girona, Spain, 17520